MR spectroscopy imaging reveals effects of targeted treatment of mutant IDH1 gliomas. ScienceDaily . Retrieved May 16, 2025 from www.sciencedaily.com / releases / 2018 / 05 / 180518164050.htm ...

Optic glioma is a brain tumor that grows slowly. Around 75% of diagnoses occur in children younger than 10 years old. Optic glioma accounts for approximately 5% of all childhood brain tumors.

Assessment of low-grade glioma treatment response remains as much of a challenge as the treatment itself. Proton magnetic resonance spectroscopy (1H-MRS) and imaging were incorporated into a study ...

Glioma is a type of brain cancer. It is the most common type of brain cancer in adults. There are different subtypes of glioma. Learn more.

image: Three-dimensional magnetic resonance spectroscopy imaging reveals a decrease in tumor levels of 2-hydroxyglurate ... "Gliomas are aggressive, ...

Using a novel imaging method, a Massachusetts General Hospital (MGH) research team is investigating the mechanisms behind a potential targeted treatment for a subtype of the deadly brains tumors ...

Proton magnetic resonance spectroscopy (MRS) of the brain can detect 2-hydroxyglutarate (2HG), the oncometabolite produced in neoplasms harboring a mutation in the gene coding for isocitrate ...

As an example, human brain gliomas are among the most common and deadly pathologies of the brain, constituting ≃ 26% of all primary brain tumors and ≃ 81% of malignant primary brain tumors. Gliomas ...

During surgeries on 17 glioma patients, the researchers used the Raman probe in conjunction with magnetic resonance imaging, a conventional method surgeons use to find the borders of brain tumors.

An increasing amount of research shows that LAT1/4F2hc is over-expressed in a variety of human tumors. Is it useful as a prognostic marker and/or potential therapeutic target in gliomas?